BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dan X, Mushi Z, Baili W, Han L, Enqi W, Huanhu Z, Shuchun L. Differential Analysis of Hypertension-Associated Intestinal Microbiota. Int J Med Sci 2019;16:872-81. [PMID: 31337961 DOI: 10.7150/ijms.29322] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 10.3] [Reference Citation Analysis]
Number Citing Articles
1 Canale MP, Noce A, Di Lauro M, Marrone G, Cantelmo M, Cardillo C, Federici M, Di Daniele N, Tesauro M. Gut Dysbiosis and Western Diet in the Pathogenesis of Essential Arterial Hypertension: A Narrative Review. Nutrients 2021;13:1162. [PMID: 33915885 DOI: 10.3390/nu13041162] [Reference Citation Analysis]
2 Liu F, Zhang N, Jiang P, Zhai Q, Li C, Yu D, Wu Y, Zhang Y, Lv L, Xu X, Feng N. Characteristics of the urinary microbiome in kidney stone patients with hypertension. J Transl Med 2020;18:130. [PMID: 32183836 DOI: 10.1186/s12967-020-02282-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
3 Vasquez EC, Aires R, Ton AMM, Amorim FG. New Insights on the Beneficial Effects of the Probiotic Kefir on Vascular Dysfunction in Cardiovascular and Neurodegenerative Diseases. CPD 2020;26:3700-10. [DOI: 10.2174/1381612826666200304145224] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
4 Louca P, Menni C, Padmanabhan S. Genomic Determinants of Hypertension With a Focus on Metabolomics and the Gut Microbiome. Am J Hypertens 2020;33:473-81. [PMID: 32060494 DOI: 10.1093/ajh/hpaa022] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
5 Paeslack N, Mimmler M, Becker S, Gao Z, Khuu MP, Mann A, Malinarich F, Regen T, Reinhardt C. Microbiota-derived tryptophan metabolites in vascular inflammation and cardiovascular disease. Amino Acids 2022. [PMID: 35451695 DOI: 10.1007/s00726-022-03161-5] [Reference Citation Analysis]
6 Daliri EB, Ofosu FK, Chelliah R, Lee BH, An H, Elahi F, Barathikannan K, Kim JH, Oh DH. Influence of fermented soy protein consumption on hypertension and gut microbial modulation in spontaneous hypertensive rats. Biosci Microbiota Food Health 2020;39:199-208. [PMID: 33117618 DOI: 10.12938/bmfh.2020-001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
7 Donertas Ayaz B, Zubcevic J. Gut microbiota and neuroinflammation in pathogenesis of hypertension: A potential role for hydrogen sulfide. Pharmacol Res 2020;153:104677. [PMID: 32023431 DOI: 10.1016/j.phrs.2020.104677] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
8 Sun S, Lei OK, Nie J, Shi Q, Xu Y, Kong Z. Effects of Low-Carbohydrate Diet and Exercise Training on Gut Microbiota. Front Nutr 2022;9:884550. [DOI: 10.3389/fnut.2022.884550] [Reference Citation Analysis]
9 Lin YT, Lin TY, Hung SC, Liu PY, Hung WC, Tsai WC, Tsai YC, Delicano RA, Chuang YS, Kuo MC, Chiu YW, Wu PH. Differences in the Microbial Composition of Hemodialysis Patients Treated with and without β-Blockers. J Pers Med 2021;11:198. [PMID: 33809103 DOI: 10.3390/jpm11030198] [Reference Citation Analysis]
10 Avery EG, Bartolomaeus H, Maifeld A, Marko L, Wiig H, Wilck N, Rosshart SP, Forslund SK, Müller DN. The Gut Microbiome in Hypertension: Recent Advances and Future Perspectives. Circ Res 2021;128:934-50. [PMID: 33793332 DOI: 10.1161/CIRCRESAHA.121.318065] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Davis GK, Fehrenbach DJ, Madhur MS. Interleukin 17A: Key Player in the Pathogenesis of Hypertension and a Potential Therapeutic Target. Curr Hypertens Rep 2021;23:13. [PMID: 33666761 DOI: 10.1007/s11906-021-01128-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Jennings A, Koch M, Bang C, Franke A, Lieb W, Cassidy A. Microbial Diversity and Abundance of Parabacteroides Mediate the Associations Between Higher Intake of Flavonoid-Rich Foods and Lower Blood Pressure. Hypertension 2021;78:1016-26. [PMID: 34420369 DOI: 10.1161/HYPERTENSIONAHA.121.17441] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Yan X, Chen X, Tian X, Qiu Y, Wang J, Yu G, Dong N, Feng J, Xie J, Nalesnik M, Niu R, Xiao B, Song G, Quinones S, Ren X. Co-exposure to inorganic arsenic and fluoride prominently disrupts gut microbiota equilibrium and induces adverse cardiovascular effects in offspring rats. Sci Total Environ 2021;767:144924. [PMID: 33636766 DOI: 10.1016/j.scitotenv.2020.144924] [Reference Citation Analysis]
14 Suganya K, Son T, Kim KW, Koo BS. Impact of gut microbiota: How it could play roles beyond the digestive system on development of cardiovascular and renal diseases. Microb Pathog 2021;152:104583. [PMID: 33164814 DOI: 10.1016/j.micpath.2020.104583] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
15 Silveira-Nunes G, Durso DF, Jr LRAO, Cunha EHM, Maioli TU, Vieira AT, Speziali E, Corrêa-Oliveira R, Martins-Filho OA, Teixeira-Carvalho A, Franceschi C, Rampelli S, Turroni S, Brigidi P, Faria AMC. Hypertension Is Associated With Intestinal Microbiota Dysbiosis and Inflammation in a Brazilian Population. Front Pharmacol 2020;11:258. [PMID: 32226382 DOI: 10.3389/fphar.2020.00258] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 10.0] [Reference Citation Analysis]
16 Dan X, Mushi Z, Baili W, Han L, Enqi W, Huanhu Z, Shuchun L. Erratum: Differential Analysis of Hypertension-Associated Intestinal Microbiota. Int J Med Sci 2021;18:3748. [PMID: 34790049 DOI: 10.7150/ijms.65972] [Reference Citation Analysis]
17 Palmu J, Lahti L, Niiranen T. Targeting Gut Microbiota to Treat Hypertension: A Systematic Review. Int J Environ Res Public Health 2021;18:1248. [PMID: 33561095 DOI: 10.3390/ijerph18031248] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
18 Cookson TA. Bacterial-Induced Blood Pressure Reduction: Mechanisms for the Treatment of Hypertension via the Gut. Front Cardiovasc Med 2021;8:721393. [PMID: 34485420 DOI: 10.3389/fcvm.2021.721393] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Guo Y, Li X, Wang Z, Yu B. Gut Microbiota Dysbiosis in Human Hypertension: A Systematic Review of Observational Studies. Front Cardiovasc Med 2021;8:650227. [PMID: 34055933 DOI: 10.3389/fcvm.2021.650227] [Reference Citation Analysis]
20 Thomaz FS, Altemani F, Panchal SK, Worrall S, Dekker Nitert M. The influence of wasabi on the gut microbiota of high-carbohydrate, high-fat diet-induced hypertensive Wistar rats. J Hum Hypertens 2021;35:170-80. [PMID: 32457512 DOI: 10.1038/s41371-020-0359-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
21 Ishimwe JA, Akinleye A, Johnson AC, Garrett MR, Sasser JM. Gestational gut microbial remodeling is impaired in a rat model of preeclampsia superimposed on chronic hypertension. Physiol Genomics 2021;53:125-36. [PMID: 33491590 DOI: 10.1152/physiolgenomics.00121.2020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
22 Zhao R, Yang S, Li D, Liu L, Xing Y, Wu M. Effects of Baduanjin Exercise on Antihypertensive Medication Reduction in Older Patients with Hypertension: A Study Protocol for a Randomized Controlled Trial. Evid Based Complement Alternat Med 2021;2021:8663022. [PMID: 34335840 DOI: 10.1155/2021/8663022] [Reference Citation Analysis]
23 Yang T, Chakraborty S, Mandal J, Mei X, Joe B. Microbiota and Metabolites as Factors Influencing Blood Pressure Regulation. Compr Physiol 2021;11:1731-57. [PMID: 33792901 DOI: 10.1002/cphy.c200009] [Reference Citation Analysis]
24 Masenga SK, Hamooya B, Hangoma J, Hayumbu V, Ertuglu LA, Ishimwe J, Rahman S, Saleem M, Laffer CL, Elijovich F, Kirabo A. Recent advances in modulation of cardiovascular diseases by the gut microbiota. J Hum Hypertens 2022. [PMID: 35469059 DOI: 10.1038/s41371-022-00698-6] [Reference Citation Analysis]
25 Joishy TK, Jha A, Oudah M, Das S, Adak A, Deb D, Khan MR, Moreira TMM. Human Gut Microbes Associated with Systolic Blood Pressure. International Journal of Hypertension 2022;2022:1-12. [DOI: 10.1155/2022/2923941] [Reference Citation Analysis]
26 Naqvi S, Asar TO, Kumar V, Al-Abbasi FA, Alhayyani S, Kamal MA, Anwar F. A cross-talk between gut microbiome, salt and hypertension. Biomed Pharmacother 2021;134:111156. [PMID: 33401080 DOI: 10.1016/j.biopha.2020.111156] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
27 Louca P, Nogal A, Wells PM, Asnicar F, Wolf J, Steves CJ, Spector TD, Segata N, Berry SE, Valdes AM, Menni C. Gut microbiome diversity and composition is associated with hypertension in women. J Hypertens 2021;39:1810-6. [PMID: 33973959 DOI: 10.1097/HJH.0000000000002878] [Reference Citation Analysis]
28 Silva CBP, Elias-Oliveira J, McCarthy CG, Wenceslau CF, Carlos D, Tostes RC. Ethanol: striking the cardiovascular system by harming the gut microbiota. Am J Physiol Heart Circ Physiol 2021;321:H275-91. [PMID: 34142885 DOI: 10.1152/ajpheart.00225.2021] [Reference Citation Analysis]
29 Młynarska E, Gadzinowska J, Tokarek J, Forycka J, Szuman A, Franczyk B, Rysz J. The Role of the Microbiome-Brain-Gut Axis in the Pathogenesis of Depressive Disorder. Nutrients 2022;14:1921. [DOI: 10.3390/nu14091921] [Reference Citation Analysis]
30 Hsu CN, Yang HW, Hou CY, Chang-Chien GP, Lin S, Tain YL. Melatonin Prevents Chronic Kidney Disease-Induced Hypertension in Young Rat Treated with Adenine: Implications of Gut Microbiota-Derived Metabolites. Antioxidants (Basel) 2021;10:1211. [PMID: 34439458 DOI: 10.3390/antiox10081211] [Reference Citation Analysis]
31 Yano Y, Niiranen TJ. Gut Microbiome over a Lifetime and the Association with Hypertension. Curr Hypertens Rep 2021;23:15. [PMID: 33686539 DOI: 10.1007/s11906-021-01133-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Verhaar BJH, Prodan A, Nieuwdorp M, Muller M. Gut Microbiota in Hypertension and Atherosclerosis: A Review. Nutrients 2020;12:E2982. [PMID: 33003455 DOI: 10.3390/nu12102982] [Cited by in Crossref: 14] [Cited by in F6Publishing: 19] [Article Influence: 7.0] [Reference Citation Analysis]
33 Wang P, Dong Y, Zuo K, Han C, Jiao J, Yang X, Li J. Characteristics and variation of fecal bacterial communities and functions in isolated systolic and diastolic hypertensive patients. BMC Microbiol 2021;21:128. [PMID: 33902467 DOI: 10.1186/s12866-021-02195-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Donertas Ayaz B, Oliveira AC, Malphurs WL, Redler T, de Araujo AM, Sharma RK, Sirmagul B, Zubcevic J. Central Administration of Hydrogen Sulfide Donor NaHS Reduces Iba1-Positive Cells in the PVN and Attenuates Rodent Angiotensin II Hypertension. Front Neurosci 2021;15:690919. [PMID: 34602965 DOI: 10.3389/fnins.2021.690919] [Reference Citation Analysis]